Dr. Liu co-founded OncoImmune and led it until its acquisition by Merck. Dr. Liu is recognized internationally for his research on immune recognition of cancer and activation of lymphocytes, the main immune defender against cancer. He has received the Markey Scholar Award (1992), and the Sears Scholar Award (1993), and Snyder Award for Cancer Research (2015) and was elected to the rank of fellow at the American Association for Advancement of Science (AAAS) in 2004 for his pioneering contribution to Innate Immunity, T cell costimulation and cancer immunology. Dr. Liu received his Ph.D. from the Australian National University, and postdoctoral fellowship from Yale University. Prior to serving full-time as OncoC4 CEO, Dr. Liu was a faculty in multiple academic institutions, including New York University, the Ohio State University, the Children’s National Medical Center and Institute of Human Virology at University of Maryland School of Medicine.